Published in FEBS Lett on December 21, 1992
A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A (1996) 11.37
GSK3 takes centre stage more than 20 years after its discovery. Biochem J (2001) 7.74
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J (1998) 7.59
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev (2006) 3.30
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res (2006) 3.12
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J Cell Biol (1994) 2.61
Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med (2012) 2.39
Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29
Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen. J Cell Biol (1998) 2.20
Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci U S A (1995) 2.18
Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell (1995) 2.15
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85
Domains of neuronal microtubule-associated proteins and flexural rigidity of microtubules. J Cell Biol (1997) 1.84
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol (2002) 1.78
Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther (2014) 1.77
Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum Mol Genet (2011) 1.72
Dishevelled-1 regulates microtubule stability: a new function mediated by glycogen synthase kinase-3beta. J Cell Biol (2000) 1.52
Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J (1997) 1.42
The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell (1998) 1.41
Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A (2009) 1.29
Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton (2009) 1.28
Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc Natl Acad Sci U S A (1996) 1.28
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet (2010) 1.23
The pool of map kinase associated with microtubules is small but constitutively active. Mol Biol Cell (1996) 1.19
Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci U S A (2000) 1.14
Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging (2007) 1.14
Paired helical filament tau in Alzheimer's disease. The kinase connection. Am J Pathol (1994) 1.12
The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med (1997) 1.11
Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. Mol Biol Cell (1995) 1.10
Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum Mol Genet (2008) 1.09
Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A (1994) 1.09
Why should stationary plant cells have such dynamic microtubules? Mol Biol Cell (1994) 1.05
Phosphorylation of threonine-19 of PSD-95 by GSK-3β is required for PSD-95 mobilization and long-term depression. J Neurosci (2013) 1.04
Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol (1994) 1.02
Yeast glycogen synthase kinase 3 is involved in protein degradation in cooperation with Bul1, Bul2, and Rsp5. Mol Cell Biol (2000) 1.02
Changes in the ageing brain in health and disease. Philos Trans R Soc Lond B Biol Sci (1997) 1.01
Mitogen-activated protein kinase/extracellular signal-regulated kinase 2 regulates cytoskeletal organization and chemotaxis via catalytic and microtubule-specific interactions. Mol Biol Cell (1997) 0.99
GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis (2011) 0.97
Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Am J Pathol (1994) 0.97
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease. Br J Pharmacol (2011) 0.96
Wound-induced expression and activation of WIG, a novel glycogen synthase kinase 3. Plant Cell (2000) 0.96
Neurofilamentopathy in neurodegenerative diseases. Open Neurol J (2011) 0.96
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacol Ther (2013) 0.94
Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem Biophys Res Commun (2008) 0.94
Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol Med (2011) 0.93
Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am J Pathol (1995) 0.93
Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain. PLoS One (2010) 0.92
Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am J Pathol (1995) 0.92
Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem J (1997) 0.92
LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6. Hum Mol Genet (2012) 0.89
The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels. Exp Cell Res (2006) 0.89
GSK-3beta phosphorylation of functionally distinct tau isoforms has differential, but mild effects. Mol Neurodegener (2009) 0.89
Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease. Biochim Biophys Acta (2015) 0.88
The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. J Pharm Pharmacol (Los Angel) (2013) 0.88
Pseudohyperphosphorylation causing AD-like changes in tau has significant effects on its polymerization. Biochemistry (2009) 0.87
Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers. Br J Pharmacol (2012) 0.86
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging. Neurobiol Aging (2011) 0.85
β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway. J Neurochem (2010) 0.85
Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. Front Aging Neurosci (2014) 0.83
Tau phosphorylation at serine 396 residue is required for hippocampal LTD. J Neurosci (2015) 0.83
Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study. J Neurol (2008) 0.83
Diabetes and Alzheimer's disease - is there a connection? Rev Diabet Stud (2007) 0.82
Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress. PLoS One (2013) 0.82
Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion. J Biol Chem (2014) 0.82
The regulation and deregulation of Wnt signaling by PARK genes in health and disease. J Mol Cell Biol (2013) 0.82
Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster. Genetics (2010) 0.81
Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells. Proc Natl Acad Sci U S A (1995) 0.81
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. World J Diabetes (2015) 0.80
Presenilins regulate the cellular level of the tumor suppressor PTEN. Neurobiol Aging (2007) 0.80
Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites. PLoS One (2014) 0.80
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice. Neuropsychopharmacology (2016) 0.80
Alois Alzheimer revisited: differences in origin of the disease carrying his name. J Neural Transm (Vienna) (2006) 0.79
Indirubin-3'-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation. Neural Regen Res (2016) 0.79
The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes. Cell Mol Neurobiol (1999) 0.78
Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate. Brain (2016) 0.78
Glycogen-synthase kinase-3beta is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment. Exp Gerontol (2009) 0.78
Phosphorylation of tau protein over time in rats subjected to transient brain ischemia. Neural Regen Res (2013) 0.78
A novel mass spectrometry-based assay for GSK-3beta activity. BMC Biochem (2005) 0.77
Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex. J Neural Transm (Vienna) (1997) 0.77
Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia. Int J Alzheimers Dis (2011) 0.75
Understanding and treating neurodegeneration: insights from the flies. Age (Dordr) (2005) 0.75
Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma. Front Neurosci (2017) 0.75
Influence of phosphorylation on isoform composition and function of a microtubule-associated protein from developing Artemia. Biochem J (1995) 0.75
Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product. Nucleic Acids Res (1984) 12.11
Microtubule dynamics and microtubule caps: a time-resolved cryo-electron microscopy study. J Cell Biol (1991) 5.16
MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell (1997) 4.75
Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol (1998) 3.53
Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A (2000) 3.49
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol (2002) 3.35
Domains of tau protein and interactions with microtubules. Biochemistry (1994) 3.23
Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell (2001) 3.19
The crystal structure of dimeric kinesin and implications for microtubule-dependent motility. Cell (1997) 3.17
Structure of actin-containing filaments from two types of non-muscle cells. J Mol Biol (1977) 2.96
Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron (1993) 2.84
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem (2001) 2.79
Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell (1999) 2.67
Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem (1994) 2.61
On the role of calcium as second messenger in liver for the hormonally induced activation of glycogen phosphorylase. Biochim Biophys Acta (1977) 2.46
Recombinant kinesin motor domain binds to beta-tubulin and decorates microtubules with a B surface lattice. Proc Natl Acad Sci U S A (1993) 2.37
Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci (1999) 2.36
Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc Natl Acad Sci U S A (1994) 2.34
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem (2001) 2.32
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol (1992) 2.20
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging (2003) 2.19
Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J (1992) 2.16
Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell (1995) 2.15
Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J (1996) 2.15
Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry (1998) 2.13
Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry (2002) 2.00
A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A (1998) 1.97
Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem (1995) 1.95
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur J Biochem (2000) 1.93
Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry (2000) 1.93
RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett (1996) 1.90
Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament-like conformation. J Biol Chem (2000) 1.90
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry (1999) 1.88
Domains of neuronal microtubule-associated proteins and flexural rigidity of microtubules. J Cell Biol (1997) 1.84
Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J Biol Chem (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells. Biochem J (1994) 1.75
Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett (1993) 1.74
Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci U S A (1995) 1.73
A new look at the microtubule binding patterns of dimeric kinesins. J Mol Biol (2000) 1.73
Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem Biol (2000) 1.71
X-ray structure of motor and neck domains from rat brain kinesin. Biochemistry (1997) 1.71
Reconstitution of intermediate-sized filaments from denatured monomeric vimentin. J Mol Biol (1981) 1.70
Unstained microtubules studied by cryo-electron microscopy. Substructure, supertwist and disassembly. J Mol Biol (1985) 1.69
Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain. EMBO J (2001) 1.68
Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motil Cytoskeleton (1999) 1.54
Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem (2000) 1.52
Motor proteins of the kinesin family. Structures, variations, and nucleotide binding sites. Eur J Biochem (1999) 1.51
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A (2007) 1.50
Tau in Alzheimer's disease. Trends Cell Biol (1998) 1.50
Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology (1975) 1.49
On the surface lattice of microtubules: helix starts, protofilament number, seam, and handedness. J Cell Biol (1986) 1.47
The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett (1992) 1.45
Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem (1998) 1.44
Tubulin protofilaments and kinesin-dependent motility. J Cell Biol (1992) 1.42
Stages of tubulin assembly and disassembly studied by time-resolved synchrotron X-ray scattering. J Mol Biol (1983) 1.42
Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics. J Biol Chem (1996) 1.42
The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell (1998) 1.41
Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation. J Cell Biol (1989) 1.40
Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci U S A (2006) 1.36
Image reconstructions of microtubules decorated with monomeric and dimeric kinesins: comparison with x-ray structure and implications for motility. J Cell Biol (1998) 1.35
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis (1974) 1.32
The activation of liver phosphorylase b kinase by glucagon. FEBS Lett (1976) 1.31
ATP x Mg-dependent protein phosphatase from rabbit skeletal muscle. II. Purification of the activating factor and its characterization as a bifunctional protein also displaying synthase kinase activity. J Biol Chem (1980) 1.31
Role of fimbrin and villin in determining the interfilament distances of actin bundles. Nature (1983) 1.31
Crystal structure of UDP-N-acetylglucosamine enolpyruvyltransferase, the target of the antibiotic fosfomycin. Structure (1996) 1.28
Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis. J Biol Chem (2000) 1.27
Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A (1992) 1.26